Publications 2024

Bramness JG, Hjorthøj C, Niemelä S, Taipale H, Rognli EB (2024)
Discussing the concept of substance-induced psychosis (SIP)
Psychol Med, 1-5 (in press)
DOI 10.1017/S0033291724001442, PubMed 39252388

Bramness JG, Hjorthøj C, Niemelä S, Taipale H, Rognli EB (2024)
Problematic diagnosis of substance-induced disorders in ICD-11
Eur Psychiatry, 67 (1), e51
DOI 10.1192/j.eurpsy.2024.1763, PubMed 39291557

Leonhardt M, Bramness JG, Rognli EB, Lien L (2024)
Frequency and patterns of substance-induced psychosis in persons with concurrent mental health and substance use disorders during the COVID-19 pandemic: A Norwegian register-based cohort study
Eur Psychiatry, 67 (1), e82
DOI 10.1192/j.eurpsy.2024.1797, PubMed 39676544

Myhre MØ, Rognli EB, Walby FA, Bramness JG, Mehlum L (2024)
The annual trend of suicide rates from 2010 to 2021 in patients with cannabis use disorder - a national registry study
Soc Psychiatry Psychiatr Epidemiol (in press)
DOI 10.1007/s00127-024-02781-4, PubMed 39466446

Rodríguez-Cano R, Lotre K, von Soest T, Rognli EB, Bramness JG (2024)
Loneliness in adolescence and prescription of psychotropic drugs in adulthood: 23-year longitudinal population-based and registry study
BJPsych Open, 10 (2), e61
DOI 10.1192/bjo.2024.22, PubMed 38465662

Rognli EB, Bukten A, Bramness JG, Stavseth MR (2024)
[Not Available]
Tidsskr Nor Laegeforen, 144 (9)
DOI 10.4045/tidsskr.23.0850, PubMed 39166997

Rognli EB, Høye A, Bramness JG (2024)
Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention: Response to Zhu et al
Am J Psychiatry, 181 (2), 168-169
DOI 10.1176/appi.ajp.20230522, PubMed 38298080

Publications 2023

Bramness JG, Syse A, Rognli EB (2023)
[Substance-induced psychosis – a problematic diagnosis]
Tidsskr Nor Laegeforen, 143 (3)
DOI 10.4045/tidsskr.22.0762, PubMed 36811432

Rognli EB, Dalsrud MK, Wüsthoff LEC, Arnevik EA (2023)
[Poor uptake of service provision at a drug-related emergency department – a qualitative study]
Tidsskr Nor Laegeforen, 143 (5)
DOI 10.4045/tidsskr.22.0471, PubMed 36987889

Rognli EB, Heiberg IH, Jacobsen BK, Høye A, Bramness JG (2023)
Transition From Substance-Induced Psychosis to Schizophrenia Spectrum Disorder or Bipolar Disorder
Am J Psychiatry, 180 (6), 437-444
DOI 10.1176/appi.ajp.22010076, PubMed 37132221

Publications 2022

Bolstad I, Alakokkare AE, Bramness JG, Rognli EB, Levola J, Mustonen A, Miettunen J, Niemelä S (2022)
The relationships between use of alcohol, tobacco and coffee in adolescence and mood disorders in adulthood
Acta Psychiatr Scand, 146 (6), 594-603
DOI 10.1111/acps.13506, PubMed 36177725

Bukten A, Lokdam NT, Skjærvø I, Ugelvik T, Skurtveit S, Gabrhelík R, Skardhamar T, Lund IO, Havnes IA, Rognli EB, Chang Z, Fazel S, Friestad C, Hesse M, Lothe J, Ploeg G, Dirkzwager AJE, Clausen T, Tjagvad C, Stavseth MR (2022)
PriSUD-Nordic-Diagnosing and Treating Substance Use Disorders in the Prison Population: Protocol for a Mixed Methods Study
JMIR Res Protoc, 11 (3), e35182
DOI 10.2196/35182, PubMed 35320114

Edvardsen HME, Aamodt C, Bogstrand ST, Krajci P, Vindenes V, Rognli EB (2022)
Concentrations of psychoactive substances in blood samples from non-fatal and fatal opioid overdoses
Br J Clin Pharmacol, 88 (10), 4494-4504
DOI 10.1111/bcp.15365, PubMed 35470456

Rognli EB, Støme LN, Kværner KJ, Wilhelmsen C, Arnevik EA (2022)
The effect of employment support integrated in substance use treatment: A health economic cost-effectiveness simulation of three different interventions
Nordisk Alkohol Nark, 40 (2), 199-211
DOI 10.1177/14550725221122196, PubMed 37063816

Rognli EB, Taipale H, Hjorthøj C, Mittendorfer-Rutz E, Bramness JG, Heiberg IH, Niemelä S (2022)
Annual incidence of substance-induced psychoses in Scandinavia from 2000 to 2016
Psychol Med, 53 (11), 5246-5255
DOI 10.1017/S003329172200229X, PubMed 35983644

Publications 2021

Rognli EB, Bramness JG, von Soest T (2021)
Smoking in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, antidepressants and anxiolytics
Psychol Med, 52 (14), 3241-3250
DOI 10.1017/S0033291720005401, PubMed 33583454

Rognli EB, Aas EM, Drake RE, Marsden J, Anders P, Bond GR, Lystad JU, Reme SE, Arnevik EA (2021)
The effect evaluation of Individual Placement and Support (IPS) for patients with substance use disorders: study protocol for a randomized controlled trial of IPS versus enhanced self-help
Trials, 22 (1), 705
DOI 10.1186/s13063-021-05673-z, PubMed 34654464

Publications 2020

Bukten A, Lund IO, Kinner SA, Rognli EB, Havnes IA, Muller AE, Stavseth MR (2020)
Factors associated with drug use in prison - results from the Norwegian offender mental health and addiction (NorMA) study
Health Justice, 8 (1), 10
DOI 10.1186/s40352-020-00112-8, PubMed 32399643

Havnes IA, Bukten A, Rognli EB, Muller AE (2020)
Use of anabolic-androgenic steroids and other substances prior to and during imprisonment - Results from the Norwegian Offender Mental Health and Addiction (NorMA) study
Drug Alcohol Depend, 217, 108255
DOI 10.1016/j.drugalcdep.2020.108255, PubMed 32949884

Publications 2019

Rognli EB, Bramness JG, von Soest T (2019)
Cannabis use in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, and antidepressants
Acta Psychiatr Scand, 141 (2), 149-156
DOI 10.1111/acps.13104, PubMed 31560790

Publications 2018

Muller AE, Havnes IA, Rognli EB, Bukten A (2018)
Inmates with Harmful Substance Use Increase Both Exercise and Nicotine Use Under Incarceration
Int J Environ Res Public Health, 15 (12)
DOI 10.3390/ijerph15122663, PubMed 30486386

Ringen PA, Faerden A, Antonsen B, Falk RS, Mamen A, Rognli EB, Solberg DK, Andreassen OA, Martinsen EW (2018)
Cardiometabolic risk factors, physical activity and psychiatric status in patients in long-term psychiatric inpatient departments
Nord J Psychiatry, 72 (4), 296-302
DOI 10.1080/08039488.2018.1449012, PubMed 29523041

Ringen PA, Falk RS, Antonsen B, Faerden A, Mamen A, Rognli EB, Solberg DK, Martinsen EW, Andreassen OA (2018)
Using motivational techniques to reduce cardiometabolic risk factors in long term psychiatric inpatients: a naturalistic interventional study
BMC Psychiatry, 18 (1), 255
DOI 10.1186/s12888-018-1832-6, PubMed 30111298

Publications 2016

Bramness JG, Rognli EB (2016)
Psychosis induced by amphetamines
Curr Opin Psychiatry, 29 (4), 236-41
DOI 10.1097/YCO.0000000000000254, PubMed 27175554

Rognli EB, Bramness JG, Skurtveit S, Bukten A (2016)
Substance use and sociodemographic background as risk factors for lifetime psychotic experiences in a non-clinical sample
J Subst Abuse Treat, 74, 42-47
DOI 10.1016/j.jsat.2016.12.007, PubMed 28132699

Publications 2015

Bukten A, Lund IO, Rognli EB, Stavseth MR, Lobmaier P, Skurtveit S, Clausen T, Kunøe N (2015)
The Norwegian Offender Mental Health and Addiction Study - Design and Implementation of a National Survey and Prospective Cohort Study
Subst Abuse, 9 (Suppl 2), 59-66
DOI 10.4137/SaRt.S23546, PubMed 26648732

Medhus S, Rognli EB, Gossop M, Holm B, Mørland J, Bramness JG (2015)
Amphetamine-induced psychosis: Transition to schizophrenia and mortality in a small prospective sample
Am J Addict, 24 (7), 586-9
DOI 10.1111/ajad.12274, PubMed 26332037

Rognli EB, Berge J, Håkansson A, Bramness JG (2015)
Long-term risk factors for substance-induced and primary psychosis after release from prison. A longitudinal study of substance users
Schizophr Res, 168 (1-2), 185-90
DOI 10.1016/j.schres.2015.08.032, PubMed 26359848

Rognli EB, Medhus SE, Bramness JG (2015)
[Amphetamine-induced psychosis or schizophrenia?]
Tidsskr Nor Laegeforen, 135 (3), 249-51
DOI 10.4045/tidsskr.14.1365, PubMed 25668544

Publications 2014

Rognli EB, Håkansson A, Berge J, Bramness JG (2014)
Does the pattern of amphetamine use prior to incarceration predict later psychosis?--a longitudinal study of amphetamine users in the Swedish criminal justice system
Drug Alcohol Depend, 143, 219-24
DOI 10.1016/j.drugalcdep.2014.07.037, PubMed 25146382

Publications 2012

Bramness JG, Gundersen ØH, Guterstam J, Rognli EB, Konstenius M, Løberg EM, Medhus S, Tanum L, Franck J (2012)
Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable?
BMC Psychiatry, 12, 221
DOI 10.1186/1471-244X-12-221, PubMed 23216941